Bone is not static tissue—it continuously remodels through a dance of osteoblasts building new matrix and osteoclasts clearing old material.
Stem cell therapy for Osteoporosis & Bone Health is an investigational regenerative approach that uses living cells — such as mesenchymal stem cells and exosomes — to target the disease process. MSC protocols explore support of the bone-forming environment and reduction of bone-resorbing inflammation in osteoporosis, as an adjunct to standard treatment. It is not an approved cure for Osteoporosis & Bone Health: results come from early-phase clinical trials and clinic case series, not large randomised studies, and the realistic goal is slowed progression or symptom improvement rather than reversal.
Bone is not static tissue—it continuously remodels through a dance of osteoblasts building new matrix and osteoclasts clearing old material. Osteoporosis occurs when remodelling becomes imbalanced, with too much removal and insufficient replacement, leaving a porous, fragile architecture vulnerable to fracture. Placental mesenchymal stem cells have attracted research interest because they can differentiate into osteoblasts, potentially helping restore bone-forming capacity. The mechanism appears to involve both direct cellular replacement of bone-building cells and the release of signalling molecules (cytokines) that shift the remodelling ratio back toward deposition. Early-stage trials are exploring whether cell therapy can slow or partially reverse the density loss that typically accelerates after oestrogen withdrawal in post-menopausal women, though robust efficacy data remain limited.
| Indicative cost · Bulgaria (EU) | €3,000–€8,000 |
|---|---|
| Global market cost range | €4,600–€7,350 (dvcstem.com) |
| Main cell types studied | MSCs from Amniotic Membrane |
| Approval status | Investigational |
| Registered trials (ClinicalTrials.gov) | 14 · 2 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
A review of registered clinical trials identified 14 completed or published studies in osteoporosis using cell-based approaches, predominantly with placental MSCs, alongside 2 currently recruiting trials. Trial sizes have ranged from 20 to 120 participants. Several small studies report modest improvements in bone mineral density (typically 3–8% change from baseline over 12–24 months) and some reduction in fracture markers, though methodological heterogeneity limits direct comparison. No large, multi-centre, phase III efficacy trial has yet reported.
Depending on assessment, a Osteoporosis & Bone Health protocol may draw on:
Direct costs for cell therapy in osteoporosis clinics typically fall between €4,000 and €7,500 per treatment course, depending on cell type, expansion protocols, and delivery method. Imaging (DXA scans, sometimes CT) and baseline bone-metabolism blood panels add €500–1,200. Long-term monitoring costs, including serial imaging and repeated treatments if needed, can accumulate; many centres recommend follow-up assessment at 6 and 12 months, each adding investigation charges.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Osteoporosis & Bone Health cost-by-country breakdown, or compare the best countries for Osteoporosis & Bone Health →
Before booking, check safety & regulation, the recovery climate, whether you may be a candidate, and which cell type fits Osteoporosis & Bone Health.
Full Osteoporosis & Bone Health FAQ → · Osteoporosis & Bone Health cost breakdown →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Am I a candidate? · Which cell type? · Types of clinics & best countries · Cost calculator
Medically reviewed by StemCellAtlas’s editorial team with Dr Tymur Lukyanenko (Orthopaedic Traumatologist · 20+ yrs clinical, 15+ yrs cell therapy) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Last reviewed 2026-07-23; see our editorial standards. Educational information, not medical advice; figures indicative.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment